XML 22 R4.htm IDEA: XBRL DOCUMENT v3.22.1
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
shares in Thousands, $ in Thousands
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Sales:      
Total sales, net $ 8,421 $ 9,934 $ 6,599
Cost of goods sold 2,776 3,970 1,738
Gross profit 5,645 5,964 4,861
Research and development 44 285 184
Sales and marketing 7,223 6,173 8,767
General and administrative 7,240 5,932 5,310
Total operating expenses 14,507 12,390 14,261
Operating loss (8,862) (6,426) (9,400)
Non-cash gain (loss) on changes in fair value of warrant liability 4,615 (5,216) 749
Non-cash gain on changes in fair value of embedded derivative liability 0 3 424
Other (expense) income, net (1,577) 605 (1,425)
Loss before provision for income taxes (5,824) (11,034) (9,652)
Provision for income taxes 0 (5) (6)
Net loss and comprehensive loss (5,824) (11,039) (9,658)
Less: Preferred deemed dividend 735 0 800
Less: Retained earnings reduction related to warrants down round feature triggered 0 0 29
Net loss attributable to common stockholders $ (6,559) $ (11,039) $ (10,487)
Net loss per share attributable to common stockholders (basic and diluted) (in dollars per share) $ (0.15) $ (0.31) $ (0.48)
Weighted-average shares of common stock outstanding used in computing net loss per share of common stock (basic and diluted) (in shares) 43,657 35,076 21,641
Product [Member]      
Sales:      
Total sales, net $ 8,397 $ 9,916 $ 6,556
Product and Service, Other [Member]      
Sales:      
Total sales, net $ 24 $ 18 $ 43